WHOLE EXOME SEQUENCING OF HEMIPLEGIC MIGRAINE PATIENTS SHOWS AN INCREASED BURDEN OF MISSENSE VARIANTS IN CACNA1H AND CACNA1I GENES 207 9 42. Chemin J, Monteil A, Perez-Reyes E, et al. Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability. J Physiol. 2002;540(Pt 1):3-14. 43. Cain SM, Snutch TP. Contributions of T-type calcium channel isoforms to neuronal firing. Channels (Austin, Tex). 2010;4(6):475-482. 44. Huang Z, Lujan R, Kadurin I, et al. Presynaptic HCN1 channels regulate Cav3.2 activity and neurotransmission at select cortical synapses. Nat Neurosci. 2011;14(4):478-486. 45. Pan ZH, Hu HJ, Perring P, Andrade R. T-type Ca(2+) channels mediate neurotransmitter release in retinal bipolar cells. Neuron. 2001;32(1):89-98. 46. Weiss N, Zamponi GW. Control of lowthreshold exocytosis by T-type calcium channels. Biochim Biophys Acta. 2013;1828(7):1579-1586. 47. Zamponi GW, Striessnig J, Koschak A, Dolphin AC. The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmacol Rev. 2015;67(4):821-870. 48. Choi S, Na HS, Kim J, et al. Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels. Genes Brain Behav. 2007;6(5):425431. 49. Bourinet E, Alloui A, Monteil A, et al. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J. 2005;24(2):315-324. 50. Weiss N, Zamponi GW. Genetic T-type calcium channelopathies. J Med Genet. 2020;57(1):1-10. 51. Gangarossa G, Laffray S, Bourinet E, Valjent E. T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants. Original Research. 2014;8:92. 52. Astori S, Wimmer RD, Prosser HM, et al. The Ca(V)3.3 calcium channel is the major sleep spindle pacemaker in thalamus. Proc Natl Acad Sci U S A. 2011;108(33):13823-13828. 53. Splawski I,Yoo DS,Stotz SC,et al.CACNA1H Mutations in Autism Spectrum Disorders*. J Biol Chem. 2006;281(31):22085-22091. 54. Carter MT, McMillan HJ, Tomin A, Weiss N. Compound heterozygous CACNA1H mutations associated with severe congenital amyotrophy. Channels (Austin, Tex). 2019;13(1):153-161. 55. Chen Y, Lu J, Pan H, et al. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol. 2003;54(2):239-243. 56. Gulsuner S, Walsh T, Watts AC, et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell. 2013;154(3):518-529. 57. El Ghaleb Y, Schneeberger PE, FernándezQuintero ML, et al. CACNA1I gain-offunction mutations differentially affect channel gating and cause neurodevelopmental disorders. Brain. 2021;144(7):2092-2106. 58. Maksemous N, Blayney CD, Sutherland HG, et al. Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine. Front Mol Neurosci. 2022;15:892820. 59. Gardiner AR, Jaffer F, Dale RC, et al. The clinical and genetic heterogeneity of paroxysmal dyskinesias. Brain. 2015;138(Pt 12):3567-3580. 60. Suzuki M, Van Paesschen W, Stalmans I, et al. Defective membrane expression of the Na(+)- HCO(3)(-) cotransporter NBCe1 is associated with familial migraine. Proc Natl Acad Sci U S A. 2010;107(36):15963-15968. 61. Jen JC, Wan J, Palos TP, Howard BD, Baloh RW. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology. 2005;65(4):529-534. 62. Weller CM, Leen WG, Neville BG, et al. A novel SLC2A1 mutation linking hemiplegic migraine with alternating hemiplegia of childhood. Cephalalgia. 2015;35(1):10-15.
RkJQdWJsaXNoZXIy MTk4NDMw